Key Background Ozempic was originally approved for Type 2 diabetes but gained popularity as a weight-loss drug
These include Alzheimers Disease where neuroprotective effects are under investigation followed by stroke under similar notion (125) Futhermore, in non-alcoholic fatty liver disease (NAFLD) they show evidence of improved liver histology and hepatic steatosis (126) in PCOS they may help in regulation of weight, reproductive and metabolic parameters simultaneously (127) GLP1-Ras are also under study with their ability to modulate the hemodynamic and inflammatory pathways to treat CKD (128) and Heart failure (129)
This means that your doctor and insurance company will need to communicate about your prescription before the insurance company will cover the drug
Habener, Svetlana Mojsov, and Jens Juul Holst, for the discovery of GLP-1 (7-37) as an insulinotropic factor and the development of GLP-1 (7-37)-based anti-diabetic and anti-obesity drugs
Save this pin for easy access
However, this requires close medical supervision due to increased hypoglycemia risk
